Apotex, Backers Raise $932 Million in Canada IPO Priced at Top

drug approval expired 40% Health

Apotex Health Corp. and its backers completed a C$1.3 billion (approximately $932 million) initial public offering in Toronto, marking the largest IPO in Canada since 2021. This significant capitalization event highlights continued investor confidence in the Canadian pharmaceutical sector.

🇨🇦 Location: Toronto — Sources: 1 — First seen: — Last seen:
IPO Apotex Health pharmaceuticals Canada fundraising

Linked Entities

Apotex Health Corp.

organization involved

Contributing Articles